DABABNEH, HUSSAM MUSA SALEM
 Distribuzione geografica
Continente #
NA - Nord America 3.840
EU - Europa 2.831
AS - Asia 2.634
AF - Africa 331
SA - Sud America 146
OC - Oceania 9
AN - Antartide 1
Totale 9.792
Nazione #
US - Stati Uniti d'America 3.789
SG - Singapore 851
GB - Regno Unito 789
CN - Cina 702
VN - Vietnam 591
IT - Italia 448
DE - Germania 403
SE - Svezia 323
HK - Hong Kong 195
RU - Federazione Russa 171
IN - India 154
FR - Francia 149
TG - Togo 136
IE - Irlanda 131
BR - Brasile 108
NL - Olanda 105
ZA - Sudafrica 71
EE - Estonia 58
UA - Ucraina 55
CI - Costa d'Avorio 53
JO - Giordania 51
FI - Finlandia 50
NG - Nigeria 45
CA - Canada 39
BE - Belgio 38
BG - Bulgaria 28
IR - Iran 23
AR - Argentina 17
JP - Giappone 17
LT - Lituania 16
CH - Svizzera 15
PL - Polonia 14
EC - Ecuador 12
AT - Austria 10
ID - Indonesia 10
AU - Australia 8
ES - Italia 8
MX - Messico 8
BD - Bangladesh 7
SC - Seychelles 7
TR - Turchia 7
GR - Grecia 6
RO - Romania 6
IQ - Iraq 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
ET - Etiopia 4
CL - Cile 3
GH - Ghana 3
PK - Pakistan 3
SN - Senegal 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
DO - Repubblica Dominicana 2
EG - Egitto 2
KE - Kenya 2
LB - Libano 2
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
DK - Danimarca 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 9.792
Città #
Southend 705
Singapore 555
Ashburn 524
Chandler 486
Fairfield 284
Hong Kong 192
Santa Clara 181
Dong Ket 180
Wilmington 171
Houston 164
Seattle 162
Princeton 153
Lomé 136
Dublin 130
Ann Arbor 127
Beijing 118
Woodbridge 113
Cambridge 93
Nanjing 82
Boardman 79
Westminster 70
Padova 68
Abidjan 53
Berlin 52
Amman 51
Medford 51
Jinan 49
New York 48
Shenyang 47
Bremen 46
Abeokuta 41
Bologna 41
Milan 39
Saint Petersburg 39
Los Angeles 38
Turin 38
Brussels 37
Ho Chi Minh City 37
Dearborn 35
Helsinki 33
Munich 33
Hanoi 32
Hebei 32
Dallas 28
Frankfurt am Main 28
London 27
Redondo Beach 27
Tianjin 27
Sofia 26
Buffalo 25
Nanchang 25
Florence 21
Jacksonville 21
Mountain View 20
Changsha 17
Falkenstein 17
Redwood City 17
Tokyo 17
Guangzhou 16
Toronto 16
Turku 16
Haikou 15
San Diego 15
Hangzhou 14
Pune 14
São Paulo 14
Düsseldorf 13
Fuzhou 12
Rome 12
Falls Church 11
Ningbo 11
Ottawa 11
Phoenix 11
Yubileyny 11
Bexley 10
Jiaxing 10
Mülheim 10
Olalla 10
Taiyuan 10
Torino 9
Kunming 8
Norwalk 8
Nuremberg 8
Shanghai 8
Taizhou 8
Zanjan 8
Zhengzhou 8
Andover 7
Chicago 7
Leawood 7
Quito 7
Redmond 7
San Venanzo 7
Warsaw 7
Wroclaw 7
Biên Hòa 6
Brooklyn 6
Haiphong 6
Konak 6
Lauterbourg 6
Totale 6.401
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 247
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 216
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 213
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 210
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 201
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 187
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 182
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 177
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 175
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 175
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 174
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 170
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 169
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 168
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 166
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 164
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 163
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 161
COMPLICANZE E MORTALITÀ PERIOPERATORIE DELLA CISTECTOMIA RADICALE: ANALISI RETROSPETTIVA UTILIZZANDO UNA CLASSIFICAZIONE STANDARDIZZATA 155
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 154
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C-COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 149
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 148
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 148
RIPARAZIONE DI LESIONE DEL RETTO IN CORSO DI PROSTATECTOMIA RADICALE ROBOTICA UTILIZZANDO UN INNESTO PERITONEALE 146
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 142
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 142
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 141
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 140
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 140
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 139
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 139
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 137
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 137
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 137
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 137
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 136
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 136
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 135
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 133
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 133
QUAL È L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO? 133
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 130
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 129
LAPAROSCOPIC AND ROBOTIC URETERAL STENOSIS REPAIR: A MULTI-INSTITUTIONAL EXPERIENCE WITH A LONG-TERM FOLLOW UP 129
LINFADENECTOMIA STANDARD VS ESTESA 128
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 127
MAGNETIC RESONANCE/ULTR ASOUND-GUIDED FUSION PROSTATE BIOPSY: CANCER DETECTION RATE WITHIN CONSECUTIVE CORES TAKEN 126
PREDICTING CANCER- SPECIFIC AND OTHER-CAUSE MORTALITY IN ELDERLY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A COMPETING RISK ANALYSIS 125
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 125
The role of standard biopsy during an MRI-TRUS fusion targeted biopsy: A two cohort study in previous negative biopsy and active surveillance patients 124
V24: A new single barbed bidirectional suture (Filbloc, Assut SPA) for posterior muscolofascial reconstruction and knotless urethrovesical anastomosis during RARP 123
RISULTATI MORFOLOGICI E FUNZIONALI DELLE NEOVESCICHE ILEALI ORTOTOPICHE:3 TECNICHE A CONFRONTO 122
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 122
PROSTATECTOMIA ROBOTICA NERVE-SPARING: RUOLO DELLA RISONANZA MAGNETICA PREOPERATORIA 121
ROBOT-ASSISTED PARTIAL URETERECTOMY WITH END-TO-END ANASTOMOSIS FOR IATROGEN STENOSIS OF THE PROXIMAL URETER 121
RUOLO DELLA TOMOGRAFIA COMPUTERIZZATA MULTIFASICA (TC) NEL MANAGEMENT CLINICO DELLE PICCOLE MASSE RENALI (SRMS). 118
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11CCOLINA-PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 116
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 116
SURVIVAL AND FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: BIFECTA ACHIEVEMENT IN PATIENTS AGED ≥ 75 YEARS 115
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 113
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 113
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 112
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11C COLINA PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 107
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 107
Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. 104
CAN TESTIS-SPARING SURGERY BE A VALID ALTERNATIVE TO RADICAL ORCHIECTOMY IN SELECTED CASES? A PROSPECTIVE STUDY 101
V32: Robot-assisted partial cystectomy for the treatment of urachus acinar adenocarcinoma 101
THE IMPACT OF PATHOLOGIC FEATURES ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER 99
QUAL'E' L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA 97
PATIENTS WITH LYMPH-NODE METASTASIS AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH-NODE DISSECTION ARE NOT ALL SUBJECT TO THE SAME RISK OF CANCER DEATH: IDENTIFYING DIFFERENT RISKCATEGORY ACCORDING TO THE NUMBER OF POSITIVE NODES AND GLEASON SCORE 91
PRESERVATION OF INTERNAL VESICAL SPHINCTER AND PROXIMAL URETHRA DURINGRADICAL PROSTATECTOMY IMPROVES EARLIERCONTINENCE RECOVERY 84
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience 15
Totale 10.016
Categoria #
all - tutte 24.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021651 0 0 0 0 0 13 33 25 106 24 18 432
2021/20221.370 204 45 64 59 137 68 21 83 35 107 302 245
2022/20231.807 194 357 120 221 112 119 46 88 330 63 112 45
2023/2024452 41 64 15 48 48 90 45 34 5 32 11 19
2024/20251.597 61 251 123 121 251 101 86 65 8 158 49 323
2025/20261.547 332 189 284 202 444 96 0 0 0 0 0 0
Totale 10.016